pharmaceuticals

(Runtime 4:03)Local pharmacists said they first learned they could be losing hundreds of customers after patients began calling them early this year.…

Pfizer's COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.

The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.

Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.

While there is anecdotal evidence hydroxychloroquine has helped manage some patients’ symptoms, there is no data that proves it is effective in treating or preventing COVID-19. But absent that kind of data, there has been confusion around how exactly to use the drug to treat patients sick with the virus — and whether it is effective.

A Texas doctor decided to give dozens of coronavirus patients at a nursing home a controversial, experimental medication, in some cases without telling their families first. He defends the decision.

The lawsuit alleges that sometimes one company would decide to raise prices on a particular drug, and other companies would follow suit. Other times, companies would agree to divide up the market rather than competing for market share by lowering prices.